Co-administration of cannabidiol and L-theanine synergistically improves sleep-related outcomes in a caffeine-induced sleep disturbance mouse model
In a mouse model of caffeine-induced sleep disturbance, combined administration of CBD and L-theanine at ratios of 1:1, 2:1, or 1:2 significantly reduced sleep onset latency and increased total sleep duration compared to single treatments. Combination index analysis indicated a synergistic interaction at lower doses, and combination treatment was associated with over 40% increases in serum serotonin and melatonin levels, as well as elevated cortical GABA levels.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Co-administration of cannabidiol and L-theanine synergistically improves sleep-related outcomes in a caffeine-induced sleep disturbance mouse model The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 26/100 (low).
The Claim
Co-administration of cannabidiol and L-theanine synergistically improves sleep-related outcomes in a caffeine-induced sleep disturbance mouse model
This conclusion is most relevant to: Caffeine-induced sleep disturbance mouse model.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Combined Administration of Cannabidiol and L-Theanine Improves Sleep-Related Outcomes in Caffeine-Induced Sleep Disturbances Mouse Model. (Biomolecules & therapeutics, 2026) —
How It Works
The proposed biological pathway:
- ▸CBD increases serotonin levels in a dose-dependent manner
- ▸L-theanine elevates serotonin at lower doses
- ▸Combination treatment elevates serum serotonin and melatonin by >40%
- ▸Combination treatment elevates cortical GABA levels
- ▸Result: Improved sleep onset latency and total sleep duration
Who Might Benefit
Evidence fit by population:
- ▸Caffeine-induced sleep disturbance mouse model
Recommended Dose
N/A (ratios tested: 1:1, 2:1, 1:2; lower doses showed synergy)
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Animal model (mice) limits direct translation to humans
- ▸Precise mechanisms remain to be determined
References
- 1.Kim J, Yu YJ, Kim HK, Ullah A, Bappi MH, Shim HJ, Cheong J, Compomayor NB, Kim HJ, Chae HJ. “Combined Administration of Cannabidiol and L-Theanine Improves Sleep-Related Outcomes in Caffeine-Induced Sleep Disturbances Mouse Model..” Biomolecules & therapeutics, 2026. PMID: 42375087 DOI: 10.4062/biomolther.2025.160